Association between lipoprotein lipase (LPL) gene and blood lipids: A common variant for a common trait?

Genetic Epidemiology

Volumn 24, Issue 4, 2003, Pages 309-321

  Morabia, Alfredo ^a   Cayanis, Eftihia ^b   Costanza, Michael C ^a   Ross, Barbara M ^b   Bernstein, Martine S ^a   Flaherty, Maria Sol ^b   Alvin, Gabriela B ^b   Das, Kamna ^b   Morris, Michael A ^a   Penchaszadeh, Graciela K ^b   Zhang, Peizen ^b   Gilliam, T Conrad ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Columbia University ^*  (United States)

Author keywords

Case control study; Genetic epidemiology; Haplotypes; Polymorphisms

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; SERINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; ATHEROGENESIS; CASE CONTROL STUDY; COVARIANCE; DISEASE PREDISPOSITION; DNA FLANKING REGION; EXON; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MALE; NUCLEOTIDE SEQUENCE; PREDICTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

CASE-CONTROL STUDIES; FEMALE; HETEROZYGOTE; HUMANS; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEIN LIPASE; LOGISTIC MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; SEX CHARACTERISTICS;

EID: 0037739943     PISSN: 07410395     EISSN: None     Source Type: Journal    
DOI: 10.1002/gepi.10229     Document Type: Article

References (28)

1. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES. 2000. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80.
2. Bernstein M, Sloutskis D, Kumanyika S, Sparti A, Schutz Y, Morabia A. 1998. A data-based approach for developing a physical activity frequency questionnaire. Am J Epidemiol 147:147-54.
3. Bernstein MS, Morabia A, Sloutskis D. 1999. Definition and prevalence of sedentarism in an urban population. Am J Public Health 89:862-7.
4. Bernstein MS, Costanza MC, James RW, Morris MA, Cambien F, Raoux S, Morabia A. 2002. Physical activity may modulate effects of ApoE genotype on lipid profile. Arterioscler Thromb Vasc Biol 22:133-40.
5. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N, Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L, Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES. 1999. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231-8.
6. Chakravarti A. 1999. Population genetics - making sense out of sequence. Nat Genet 21:56-60.
7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-3.
8. Fisher RM, Humphries SE, Talmud PJ. 1997. Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 135:145-59.
9. Groenemeijer BE, Hallman MD, Reymer PW, Gagne E, Kuivenhoven JA, Bruin T, Jansen H, Lie KI, Bruschke AV, Boerwinkle E, Hayden MR, Kastelein JJ. 1997. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation 95:2628-35.
10. Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ. 1998. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 18:526-34.
11. Kalachikov S, Evgrafov O, Ross B, Winawer M, Barker-Cummings C, Boneschi FM, Choi C, Morozov P, Das K, Teplitskaya E, Yu A, Cayanis E, Penchaszadeh G, Kottmann AH, Pedley TA, Hauser WA, Ottman R, Gilliam TC. 2002. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 30:335-41.
12. Kruglyak L, Nickerson DA. 2001. Variation is the spice of life. Nat Genet 27:234-6.
13. Lander ES. 1996. The new genomics: global views of biology. Science 274:536-9.
14. Morabia A, Bernstein M, Kumanyika S, Sorenson A, Mabiala I, Prodolliet B, Rolfo I, Luong BL. 1994. Development and validation of a semi-quantitative food questionnaire based on a population survey [in French]. Soz Praventivmed 39:345-69.
15. Morabia A, Bernstein M, Heritier S, Ylli A. 1997. Community-based surveillance of cardiovascular risk factors in Geneva: methods, resulting distributions, and comparisons with other populations. Prev Med 26:311-9.
16. Murthy V, Julien P, Gagne C. 1996. Molecular pathobiology of the human lipoprotein lipase gene. Pharmacol Ther 70: 101-35.
17. Nickerson DA, Taylor SL, Weiss KM, Clark AG, Hutchinson RG, Stengard J, Salomaa V, Vartiainen E, Boerwinkle E, Sing CF. 1998. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet 19:233-40.
18. Pritchard JK. 2001. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 69:124-37.
19. Razzaghi H, Aston CE, Hamman RF, Kamboh MI. 2000. Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels. Hum Genet 107:257-67.
20. Reich DE, Lander ES. 2001. On the allelic spectrum of human disease. Trends Genet 17:502-10.
21. Schneider S, Roessli D, Excoffier L. 2000. Arlequin: a software for population genetics data analysis [2.000]. Geneva: Genetics and Biometry Laboratory, University of Geneva, Switzerland.
22. Stephens JC, Schneider JA, Tanguay DA, Choi J, Acharya T, Stanley SE, Jiang R, Messer CJ, Chew A, Han JH, Duan J, Carr JL, Lee MS, Koshy B, Kumar AM, Zhang G, Newell WR, Windemuth A, Xu C, Kalbfleisch TS, Shaner SL, Arnold K, Schulz V, Drysdale CM, Nandabalan K, Judson RS, Ruano G, Vovis GF. 2001a. Haplotype variation and linkage disequilibrium in 313 human genes. Science 293:489-93.
23. Stephens M, Smith NJ, Donnelly P. 2001b. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-89.
24. Ukkola O, Garenc C, Perusse L, Bergeron J, Despres JP, Rao DC, Bouchard C. 2001. Genetic variation at the lipoprotein lipase locus and plasma lipoprotein and insulin levels in the Quebec Family Study. Atherosclerosis 158:199-206.
25. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. 1994. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344:1453-7.
26. Wittrup HH, Tybjaerg-Hansen A, Nordestgaard BG. 1999. Lipoprotein lipase mutations, plasma lipids and lipoproteins, and risk of ischemic heart disease. A meta-analysis. Circulation 99:2901-7.
27. Wittrup HH, Nordestgaard BG, Steffensen R, Jensen G, Tybjaerg-Hansen A. 2002. Effect of gender on phenotypic expression of the S447X mutation in LPL: the Copenhagen City Heart Study. Atherosclerosis 165:119-26.
28. Zhang H, Henderson H, Gagne SE, Clee SM, Miao L, Liu G, Hayden MR. 1996. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta 1302:159-66.